Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orchestra BioMed Holdings, Inc. - Ordinary Shares (NQ:OBIO)

2.600 -0.040 (-1.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 429,746
Open 2.680
Bid (Size) 2.530 (5)
Ask (Size) 2.630 (2)
Prev. Close 2.640
Today's Range 2.550 - 2.680
52wk Range 2.370 - 7.040
Shares Outstanding 38,194,442
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga

Performance

YTD
-51.7%
-51.7%
1 Month
-11.3%
-11.3%
3 Month
-9.4%
-9.4%
6 Month
-53.8%
-53.8%
1 Year
-55.4%
-55.4%

More News

Read More
Orchestra BioMed Announces Pricing of $40 Million Public Offering
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
Orchestra BioMed Announces Proposed Public Offering
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Sidoti Events, LLC's Virtual May Micro-Cap Conference
Via ACCESS Newswire
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
SmallCaps Gaining Momentum: TIVC, GELS, SLI, OBIO in Healthcare, Biotech, Energy, Military Defense, Etc. – More Stocks Inside
Via AB Newswire
Topics Government
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Where Orchestra BioMed Hldgs Stands With Analysts
Via Benzinga
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Power Solutions International Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Orchestra BioMed to Present at Upcoming Investor Conferences
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Orchestra BioMed Holdings, Inc. - Ordinary Shares publicly traded?
Yes, Orchestra BioMed Holdings, Inc. - Ordinary Shares is publicly traded.
What exchange does Orchestra BioMed Holdings, Inc. - Ordinary Shares trade on?
Orchestra BioMed Holdings, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Orchestra BioMed Holdings, Inc. - Ordinary Shares?
The ticker symbol for Orchestra BioMed Holdings, Inc. - Ordinary Shares is OBIO on the Nasdaq Stock Market
What is the current price of Orchestra BioMed Holdings, Inc. - Ordinary Shares?
The current price of Orchestra BioMed Holdings, Inc. - Ordinary Shares is 2.600
When was Orchestra BioMed Holdings, Inc. - Ordinary Shares last traded?
The last trade of Orchestra BioMed Holdings, Inc. - Ordinary Shares was at 08/07/25 04:00 PM ET
What is the market capitalization of Orchestra BioMed Holdings, Inc. - Ordinary Shares?
The market capitalization of Orchestra BioMed Holdings, Inc. - Ordinary Shares is 99.31M
How many shares of Orchestra BioMed Holdings, Inc. - Ordinary Shares are outstanding?
Orchestra BioMed Holdings, Inc. - Ordinary Shares has 99M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.